Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Biotechnology

Healthcare
$18.31 +0.58%

+$0.10 today

Market cap
$980.14M
Beta
0.00
52W Low $14.85High $23.00

Volume 0.68M

Average 0.41M

SPTX Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

No reported Cost of Revenue figures are available to summarize.

Cost of Revenue history

Currency unavailable · from the income statement

No Cost of Revenue data reported for this period type.

Cost of Revenue vs competitors

How SPTX compares with its peers on the latest reported figures

SPTX Competitors
Cost of Revenue for SPTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
VNDAVanda Pharmaceuticals Inc.LTM Mar 2026$16.42M USD+24.9%-18.7%7.5%
NMRANeumora Therapeutics, Inc. Common StockLTM Mar 2026$5.01M USD———
RAPPRapport Therapeutics, Inc. Common StockLTM Mar 2026$1M USD+7.4%+307.8%5.0%
MPLTMapLight Therapeutics, Inc.LTM Mar 2026$574K USD+69.3%+0.2%—
GHRSGH Research PLCLTM Mar 2026$268K USD———
LBRXLB Pharmaceuticals Inc Common StockLTM Mar 2026$82K USD———
CTNMContineum Therapeutics, Inc. Class A Common StockLTM Mar 2026$79K USD———
SPTXSeaport Therapeutics, Inc. Common Stock—— ———
Peer median (excluding SPTX) —+24.9%+0.2%6.3%

Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Intrinsic Alpha fair value

Locked

Current Price

$18.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.